Trials / Unknown
UnknownNCT01895010
Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observation on acupoint electric stimulation combined with tropisetron in preventing and treating nausea and vomiting and improving the patient's appetite after TACE for primary or metastatic liver cancer patients.
Detailed description
* Classification of nausea and vomiting, as measured by NCI CTC-AE version 3 * The improvement of appetite, as measure by the classification of Appetite in accordance with NCI CTC-AE version 3. * Quality of life: use M. D. Anderson symptom scale (the m. d. Anderson Symptom Inventory,MDASI)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | acupoint electric stimulation | acupoint electric stimulation combined with tropisetron 6mg before TACE |
| DRUG | tropisetron | only tropisetron 6mg before TACE |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-07-10
- Last updated
- 2013-07-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01895010. Inclusion in this directory is not an endorsement.